|Day Low/High||38.24 / 38.72|
|52 Wk Low/High||24.47 / 38.74|
Ionis retained all rights to inotersen and IONIS-FB-LRx as part of reprioritizing its pipeline and a strategic review of its Rare Diseases business.
112,000-Square-Foot Baltimore Facility Is Designed to Enable Surge Manufacturing of Medical Countermeasures to Address Urgent Public Health Threats
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.